DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,977 Cr | ₹12,559 Cr | ₹11,812 Cr | ₹1,055,817 Cr | ₹7,779 Cr |
What is the latest Appropriations of DIVIS LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹13,977 Cr |
| Mar2025 | ₹12,559 Cr |
| Mar2024 | ₹11,812 Cr |
| Mar2023 | ₹1,055,817 Cr |
| Mar2022 | ₹7,779 Cr |
How is Appropriations of DIVIS LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,977 Cr | 11.29 | |
| Mar2025 | ₹12,559 Cr | 6.32 | |
| Mar2024 | ₹11,812 Cr | -98.88 | |
| Mar2023 | ₹1,055,817 Cr | 13,473.41 | |
| Mar2022 | ₹7,779 Cr | - | |
Compare Appropriations of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹197,012.9 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹108,129.0 Cr | -1% | 3.7% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.2% |
10.5% |
7.7% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses